Adult-onset Still's Disease during Pregnancy Treated with Tocilizumab

Intern Med. 2022 Oct 15;61(20):3137-3140. doi: 10.2169/internalmedicine.8886-21. Epub 2022 Mar 12.

Abstract

A 28-year-old woman exhibited a spiking fever, arthritis, and liver disfunction when she was 22 weeks pregnant. She was diagnosed with adult-onset Still's disease (AOSD). As her condition was resistant to corticosteroid therapy, tocilizumab (TCZ) was selected. The TCZ treatment was effective, and she delivered a healthy child while receiving TCZ treatment. Cases in which AOSD first arises during pregnancy are rare, and there have been no reports of TCZ treatment for AOSD being initiated during pregnancy. Although the safety of TCZ treatment during pregnancy has not been established, it may be effective against severe AOSD that develops during pregnancy.

Keywords: adult-onset Still's disease; tocilizumab, pregnancy.

Publication types

  • Case Reports

MeSH terms

  • Adrenal Cortex Hormones
  • Adult
  • Antibodies, Monoclonal, Humanized* / therapeutic use
  • Female
  • Humans
  • Infant, Newborn
  • Pregnancy
  • Still's Disease, Adult-Onset* / drug therapy
  • Treatment Outcome

Substances

  • Adrenal Cortex Hormones
  • Antibodies, Monoclonal, Humanized
  • tocilizumab